Denmark · Series B startup

Who invested in LiPlasome Pharma

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$8.0Mraised across 1 round since 2005, from 1 source

Latest round
Series B, $8.0MMar 2005
Investors
3
See who backed them

The rounds

  1. Mar 2005
    Series B$8.0M

    From a historical funding record

Everyone who backed them

VecataInvestment firm1round
Incuba VentureVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about LiPlasome Pharma

Who invested in LiPlasome Pharma?

LiPlasome Pharma's investors include Vecata, BankInvest Biomedical Venture and Incuba Venture.

How much has LiPlasome Pharma raised?

LiPlasome Pharma has raised $8.0M across 1 round since 2005.

When did LiPlasome Pharma last raise?

LiPlasome Pharma's most recent round was a Series B of $8.0M in Mar 2005.

What was LiPlasome Pharma's biggest round?

Its most recent round, $8.0M in Mar 2005, is also its largest on record.

Who backed LiPlasome Pharma first?

LiPlasome Pharma's first round on record, in Mar 2005, was backed by Vecata, BankInvest Biomedical Venture and Incuba Venture.

What stage is LiPlasome Pharma at?

LiPlasome Pharma's latest named round is a Series B, in Mar 2005.

Where is LiPlasome Pharma based?

LiPlasome Pharma is based in Denmark.

Companies like LiPlasome Pharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.